$420.00
Discover the effects of Depo Provera today. This derivative of the progesterone doesn’t express any androgenic or estrogenic activity, and is highly popular in Canada.
Provera (Medroxyprogesterone) — a derivative of progesterone, rendering a progestin action and not possessing androgenic and estrogen activity. In corresponding dozes, the preparation suppresses secretion of gonadotropic hormones (especially luteinizing) and prevents ovulation.
Provera also breaks the secretory changes of the endometrium and raises the viscosity of slime of the cervix of the uterus. It increases the number of intermediate cells in an index of maturing of vaginal epithelium.
Moreover, the preparation reduces the expressiveness of vasomotor semiology at women in menopause.
The raised sensitivity to medroksiprogesteron.
Prior to the beginning of application of Provera it is necessary to exclude the presence at the patient of tumor of genitals or mammary glands (except for cases of carrying out of antineoplastic therapy). For the patients, in the anamnesis of which there are the instructions on therapy in occasion of depression, careful supervision during treatment by a preparation is required.
With reference to any patient who has attributes and/or of the symptoms corresponding to inopectic process, before continuation of therapy with Provera, it is necessary to estimate a situation repeatedly.
In some patients receiving small doses of Provera, a decrease in tolerance to glucose is possible. It is considered at purpose of a preparation to diabetics. Application Provera during pregnancy is not recommended.
If on a background of treatment by a preparation cytologic or histologic research of endometrium or cervix of the uterus is carried out, it is necessary to warn the histologist about the conducted therapy.
The application of Depo Provera can influence the results of the following laboratory researches: definition of levels of gonadotropins; definition of levels in plasma of blood of a progesterone, cortisol, estrogen; definition of a level of pregnanediol in urine; carrying out of the test with sugar loading (the test of tolerance to glucose); a metapyronic test.
The patient should inform the attending doctor:
Tell the doctor if at you were observed:
All medical products have various collateral actions. At application of Provera can be noted:
In very rare cases you can feel more hungry and thirsty more often than usual, because of a change in the level of sugar in your blood. At any similar displays inform the doctor immediately.
If these displays don’t have the simple character of easy troubles, suspend reception of tablets and address the doctor. Also talk with the doctor if any bloody allocations, continuing more than two weeks, are observed. Also address to the doctor if you have noticed at yourselves:
Application of tablets of Provera ( Medroxyprogesterone ) very seldom can lead to serious by-effects. Immediately address the doctor and stop reception of tablets if you will feel strong weakness, dyspnea or strong pains in the breast. If you will notice any other changes during reception of Provera ( Medroxyprogesterone ), inform the doctor about it.
color | Gray |
---|
You must be logged in to post a review.
Reviews
There are no reviews yet.